Judgment is expected Wednesday in a high-stakes dispute between consumer giants Kraft and Bega over who owns the rights to the signature Kraft peanut butter trade dress in Australia.
F. Hoffman La-Roche has reached a settlement in a patent lawsuit over Sandoz’s plan to market a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.
IP Australia has ordered biotech firm MacroGenics to amend its patent for a type of polypeptide used in treatments for cancer, autoimmune disorders and other diseases after a successful opposition from the chairman of intellectual property boutique Wrays.
McDonald’s is seeking the cancellation of trade marks held by famed Melbourne pub The Corner Hotel, which sued the fast food giant last year for allegedly violating its “Corner” trade marks with a experimental hipster cafe in Sydney.
The battle to acquire IP services company Xenith IP Group is set to intensify after the Australian Competition and Consumer Commission blessed a hostile offer by IPH Limited.
The Australian Competition and Consumer Commission will not oppose the merger of two companies that own some of Australia’s largest intellectual property boutiques.
Ceramic tile maker Ceramiche Caesar has appealed a judge’s decision allowing building products maker Caesarstone to register two trade marks that are deceptive similarity to one of its marks, with the judge finding Caesarstone had shown honest concurrent use of the marks.
Intellectual property powerhouse Spruson & Ferguson has bolstered the ranks of its Melbourne office with the recruitment of seasoned patent lawyer Brett Connor from FPA Patent Attorneys.
A David versus Goliath trade mark battle between an iconic Melbourne pub and McDonald’s over the global food giant’s new hipster cafe will continue, after the parties failed to reach an agreement to put the dispute to rest.
Ramsay Health Care has defeated a challenge to its Nuramel trade mark for a brand of infant formula, with IP Australia saying while the mark was an exact anagram of Biofarma’s Munarel, it wasn’t deceptively similar.